athenahealth Goes Red
athenahealth (NAS: ATHN) reported earnings on July 18. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), athenahealth met expectations on revenues and missed expectations on earnings per share.
Compared to the prior-year quarter, revenue increased significantly. Non-GAAP earnings per share dropped to a loss. GAAP earnings per share contracted to a loss.
Margins dropped across the board.
Revenue details
athenahealth logged revenue of $146.3 million. The 18 analysts polled by S&P Capital IQ expected revenue of $148.1 million on the same basis. GAAP reported sales were 41% higher than the prior-year quarter's $103.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
EPS came in at -$0.08. The 19 earnings estimates compiled by S&P Capital IQ anticipated $0.22 per share. Non-GAAP EPS were -$0.08 for Q2 versus $0.24 per share for the prior-year quarter. GAAP EPS were -$0.34 for Q2 compared to $0.11 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Margin details
For the quarter, gross margin was 59.4%, 100 basis points worse than the prior-year quarter. Operating margin was -2.9%, 830 basis points worse than the prior-year quarter. Net margin was -8.5%, much worse than the prior-year quarter. (Margins calculated in GAAP terms.)
Looking ahead
Next quarter's average estimate for revenue is $155.4 million. On the bottom line, the average EPS estimate is $0.24.
Next year's average estimate for revenue is $597.4 million. The average EPS estimate is $1.10.
Investor sentiment
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 200 members out of 254 rating the stock outperform, and 54 members rating it underperform. Among 72 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 60 give athenahealth a green thumbs-up, and 12 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on athenahealth is hold, with an average price target of $93.07.
Is athenahealth the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
Add athenahealth to My Watchlist.
The article athenahealth Goes Red originally appeared on Fool.com.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool recommends Athenahealth. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
